Annual report pursuant to Section 13 and 15(d)

INCOME TAXES (Tables)

v3.22.4
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Income (Loss) before Income Tax, Domestic and Foreign
Income (loss) before taxes on income is comprised as follows:
Year ended December 31,
2022

2021 2020
Domestic $ (7,910) $ (11,098) $ 1,241 
Foreign (8,483) 863  (853)
Total income (loss) before income taxes
$ (16,393) $ (10,235) $ 388 
Schedule of Components of Income Tax Expense (Benefit)
Income taxes are comprised as follows:
Year ended December 31,
2022

2021 2020
Current income tax provision (benefit):    
Domestic $ 1,048  $ (8) $ 96 
Foreign 2,129  1,245  1,104 
Total current income tax (benefit) provision
$ 3,177  $ 1,237  $ 1,200 
Year ended December 31,
2022

2021 2020
Deferred income tax provision (benefit):    
Domestic $ —  $ —  $ — 
Foreign (1,160) —  — 
Total deferred income tax (benefit) provision
$ (1,160) $   $  
Total income tax (benefit) provision $ 2,017  $ 1,237  $ 1,200 
Schedule of Effective Income Tax Rate Reconciliation
A reconciliation of the U. S. statutory income tax rate to the Company’s effective income tax rate for continuing operations is as follows:
Year ended December 31,
  2022 2021 2020
Total income (loss) before income taxes
$ (16,393) $ (10,235) $ 388 
US statutory rate 21  % 21  % 21  %
Income taxed computed at U. S. federal statutory rate $ (3,443) $ (2,149) $ 81 
Foreign rate differential 101  (14) (155)
State and local income taxes, net (239) (359) 207 
Other non-deductible items 546  (37) 140 
GILTI 2,892  308  — 
Change in valuation allowance 2,305  1,493  159 
Tax credits (474) (338) (469)
Changes in uncertain tax positions 1,202  881  956 
Transaction costs 1,427  578  — 
Warrants - MTM (3,081) 160  (5)
Other 781  714  286 
Total income tax provision
$ 2,017  $ 1,237  $ 1,200 
Effective income tax rate
(12.3) % (12.1) % 309.0  %
Schedule of Deferred Tax Assets and Liabilities Significant components of deferred tax assets and deferred tax liabilities consisted of the following:
  December 31,
  2022 2021
Deferred tax assets    
Loss carryforwards $ 11,093  $ 10,201 
Tax credits 1,271  1,128 
Interest limitation carryforwards —  25 
R&D capitalization costs 7,497  — 
Accrued expenses 1,157  597 
Share-based compensation 4,398  127 
Fixed assets 147  180 
Lease liabilities 700  — 
Other 28  187 
Total deferred tax assets, gross
26,291  12,445 
Valuation allowance (18,697) (12,445)
Total deferred tax assets, net
$ 7,594  $  
Deferred tax liabilities
Intangibles $ (7,239) $ — 
Right-of-use asset (654) — 
Other (190) — 
Total deferred tax liability, net
$ (8,083) $  
Total deferred tax asset (liability) $ (489) $  
Summary of Operating Loss Carryforwards
The Company’s gross NOLs for tax return purposes are as follows:
 
Year ended December 31,
  2022 2021
Domestic NOLs (federal) $ 11,881  $ 36,817 
Domestic NOLs (state and local) 10,992  36,245 
Foreign NOLs 30,804  1,136 
Total
$ 53,677  $ 74,198 
Schedule of Unrecognized Tax Benefits Roll Forward
The Company’s unrecognized tax benefits are reconciled as follows:
December 31,
2022 2021 2020
Gross unrecognized tax benefits as of January 1
$ 3,162  $ 2,373  $ 1,438 
Increases - prior year tax positions 60  508  — 
Decreases - prior year tax positions (231) (410) — 
Increases - current year tax positions 2,562  691  935 
Position expiration (97)    
Gross unrecognized tax benefits as of December 31
$ 5,456  $ 3,162  $ 2,373